These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11109255)

  • 1. Degradation of a fluoropyridinyl drug in capsule formulation: degradant identification, proposed degradation mechanism, and formulation optimization.
    Chen JG; Markovitz DA; Yang AY; Rabel SR; Pang J; Dolinsky O; Wu LS; Alasandro M
    Pharm Dev Technol; 2000; 5(4):561-70. PubMed ID: 11109255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Insight into Chemical Stability of Important Antidiabetic Drug Vildagliptin Using Chromatography (LC-UV and UHPLC-DAD-MS) and Spectroscopy (Mid-IR and NIR with PCA).
    Gumieniczek A; Berecka-Rycerz A; Fornal E; Żyżyńska-Granica B; Granica S
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of a lyophilized formulation of BMS-204352: identification of degradants and role of elastomeric closures.
    Nassar MN; Nesarikar VV; Lozano R; Huang Y; Palaniswamy V
    Pharm Dev Technol; 2005; 10(2):227-32. PubMed ID: 15926671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of formaldehyde impurity in polysorbate 80 and PEG-300 on the stability of a parenteral formulation of BMS-204352: identification and control of the degradation product.
    Nassar MN; Nesarikar VN; Lozano R; Parker WL; Huang Y; Palaniswamy V; Xu W; Khaselev N
    Pharm Dev Technol; 2004; 9(2):189-95. PubMed ID: 15202578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Unexpected Degradation Pathway of a 1,2,4-Triazolo[4,3-a]pyridine Derivative: The Formation of 2 Cationic Pseudodimers of an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor Drug Candidate in a Stressed Capsule Formulation.
    Huang Y; Wang Q; Wu Y
    J Pharm Sci; 2018 Jun; 107(6):1633-1641. PubMed ID: 29458062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and identification of a degradation product in a capsule formulation containing the elastase inhibitor, DMP 777.
    Buckley D; Haas MJ; Scholz TH; Sigvardson KW
    J Pharm Biomed Anal; 2001 Feb; 24(4):651-7. PubMed ID: 11272322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive strategy for the rapid structure elucidation of drug degradants.
    Rourick RA; Volk KJ; Klohr SE; Spears T; Kerns EH; Lee MS
    J Pharm Biomed Anal; 1996 Sep; 14(12):1743-52. PubMed ID: 8887722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Degradation caused by incompatibility between sodium stearyl fumarate (PRUV) and AZD7986 in the drug product.
    Ludvigsson JW; Wikström H; Andersson T; Norrby PO
    J Pharm Biomed Anal; 2018 Sep; 158():82-87. PubMed ID: 29860182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.
    Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V
    J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH control of nucleophilic/electrophilic oxidation.
    Freed AL; Strohmeyer HE; Mahjour M; Sadineni V; Reid DL; Kingsmill CA
    Int J Pharm; 2008 Jun; 357(1-2):180-8. PubMed ID: 18400425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method.
    Bhutani H; Singh S; Vir S; Bhutani KK; Kumar R; Chakraborti AK; Jindal KC
    J Pharm Biomed Anal; 2007 Mar; 43(4):1213-20. PubMed ID: 17118610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Degradation kinetics and mechanism of an oxadiazole derivative, design of a stable drug product for BMS-708163, a γ-secretase inhibitor drug candidate.
    Hartley RF; Huang Y; Cassidy M; Razler TM; Qian F; Hussain MA
    J Pharm Sci; 2012 Sep; 101(9):3124-33. PubMed ID: 22262489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and control of a degradation product in Avapro film-coated tablet: low dose formulation.
    Wang G; Fiske JD; Jennings SP; Tomasella FP; Palaniswamy VA; Ray KL
    Pharm Dev Technol; 2008; 13(5):393-9. PubMed ID: 18720237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stress stability of olanzapine: studies of interactions with excipients in solid state pharmaceutical formulations.
    Djordjević Filijović N; Antonijević MD; Pavlović A; Vučković I; Nikolić K; Agbaba D
    Drug Dev Ind Pharm; 2015 Mar; 41(3):502-14. PubMed ID: 24611817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.
    Wu Y
    Biomed Chromatogr; 2000 Oct; 14(6):384-96. PubMed ID: 11002276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mechanistic and kinetic study of the beta-lactone hydrolysis of Salinosporamide A (NPI-0052), a novel proteasome inhibitor.
    Denora N; Potts BC; Stella VJ
    J Pharm Sci; 2007 Aug; 96(8):2037-47. PubMed ID: 17554770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid and accurate prediction of degradant formation rates in pharmaceutical formulations using high-performance liquid chromatography-mass spectrometry.
    Darrington RT; Jiao J
    J Pharm Sci; 2004 Apr; 93(4):838-46. PubMed ID: 14999722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of the maleate salt of a basic drug by adjustment of microenvironmental pH in solid dosage form.
    Zannou EA; Ji Q; Joshi YM; Serajuddin AT
    Int J Pharm; 2007 Jun; 337(1-2):210-8. PubMed ID: 17296277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring the chemical and physical stability for tromethamine excipient in a lipid based formulation by HPLC coupled with ELSD.
    Rodríguez SA; Qiu F; Mulcey M; Weigandt K; Tamblyn T
    J Pharm Biomed Anal; 2015 Nov; 115():245-53. PubMed ID: 26254033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.